Manufacturer profileIMMUNO-MYCOLOGICS, INC.
TaiwanUnited States4 products registeredOct 19, 2005 – Sep 26, 2019
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Total products
4
Product types
4
Active products
Sep 2019
Latest registration
Company details
- Address
- 2701 CORPORATE CENTRE DRIVE NORMAN, OK 73069 USA
Regulatory footprint
Search IMMUNO-MYCOLOGICS, INC. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
"IMMY" Aspergillus ASSAY (Non-Sterile)
Registered: Sep 26, 2019 • Expires: Sep 26, 2024
- Risk Class
- Class 1
- Type
- MD
- AR
- RAFA INTERNATIONAL CORP.
"IMMY" ASPERGILLUS ASSAY (Non-sterile)
Registered: Jan 15, 2019 • Expires: Jan 15, 2024
- Risk Class
- Class 1
- Type
- MD
- AR
- FENG CHI BIOTECH CORP.
"IMMY" Cryptococcal Antigen Lateral Flow Assay (Non-Sterile)
Registered: Dec 14, 2017 • Expires: Dec 14, 2027
- Risk Class
- Class 1
- Type
- MD
- AR
- FENG CHI BIOTECH CORP.
Fengji Latex Hidden Coccus Antigen Detection System (Unsterilized)
Registered: Oct 19, 2005 • Expires: Oct 19, 2025
- Risk Class
- Class 1
- AR
- FENG CHI BIOTECH CORP.
About this profile
Explore comprehensive manufacturer profile for IMMUNO-MYCOLOGICS, INC. based in United States through Pure Global AI's free Taiwan medical device database. This manufacturer has 4 products registered in Taiwan across 4 unique product categories. Their regulatory history spans from Oct 19, 2005 to Sep 26, 2019.
This page provides detailed insights including 4 recent product registrations, 4 most popular products with "IMMY" Aspergillus ASSAY (Non-Sterile) having 1 registrations, and 2 authorized representatives including FENG CHI BIOTECH CORP.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.